$MCK

Lerman Bradley E sold $269K of MCK

Lerman Bradley E sold 301 shares of MCKESSON CORP (MCK) at $892.32 ($0.27M total) on 2026-08-10.

Original reporting
SEC EDGAR · Lerman Bradley E
Published Aug 11, 2026, 6:05 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 11, 2026, 6:08 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$MCK
Neutral
low confidence
Mentioned
$MCK
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$MCKNeutralLow
01

Why it matters

The disclosure updates the record of insider ownership and may marginally influence sentiment, but it does not introduce new operational or financial guidance.

02

Market read

Traders may note the insider sale, but there is no fundamental catalyst in the text to drive a durable repricing.

03

What to watch

Insider sales often have limited predictive value without accompanying changes in guidance, contracts, or governance actions; also, the director’s remaining holdings are reported as 0 shares, which may reflect a one-time liquidation rather than a trend.

Relevance 4/10Novelty 2/10Timing: filed 2026-08-11, transaction dated 2026-08-10

Background

The article is an SEC Form 4 insider transaction disclosure for McKesson, reported by a director.

Company-level read

Ticker impact

$MCKNeutralLow confidence
Context

McKesson Form 4 shows director Lerman Bradley E sold 301 shares on 2026-08-10 at $892.3250, exiting the position.

Expected impact

Low likelihood of a sustained price move; any reaction is likely limited to short-term sentiment.

Evidence & confidence

The filing is a Form 4 insider transaction, not earnings, guidance, or a corporate action. The article provides sale size and price but no new company-specific operating or regulatory development.

Market effects

None indicated; this is company-specific insider selling.

None indicated.

None indicated.

Counterpoint

The sale could be non-informational (taxes, diversification, or pre-planned liquidity), especially since the filing does not provide a 10b5-1 plan.

Key entities

  • MCK

    McKesson Corporation, the company whose insider transaction is disclosed.

  • Lerman Bradley E

    Director who sold 301 shares in an open-market transaction.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$MCKMedAI 8/10

McKesson Confirms Data Breach: 284M Records, $55M Demand

McKesson Corporation confirmed a data breach affecting its oncology and medical-surgical units, with 284M records allegedly stolen. The company filed an SEC report and faces a $55M ransom demand from hackers, ShinyHunters, by September 1, 2026. McKesson's CTO, Francisco Fraga, acknowledged the breach but downplayed its ongoing impact.

$MCKMed

McKesson copes with fallout from data theft extortion attack

McKesson, a major healthcare distributor, reported a cyberattack resulting in data theft and temporary service disruptions. The attack, claimed by ShinyHunters, occurred between Aug. 21-25. McKesson assured customers of operational continuity but faces a Sept. 1 ransom deadline. The company reported $403.4B in annual revenue.

$MCKMed

Hackers claim millions of patient records stolen during data breach at healthcare giant McKesson

McKesson confirmed a data breach affecting its oncology and medical-surgical units, with hackers claiming to have stolen millions of patient records, including personal and health information. The ShinyHunters group demanded a $55 million ransom. McKesson reported intermittent service issues but stated it is operating normally. The breach is part of a recent trend of cyberattacks on healthcare companies.